| Literature DB >> 33525682 |
Henkie Isahwan Ahmad Mulyadi Lai1,2, Shih-Jie Chou1,3, Yueh Chien3,4, Ping-Hsing Tsai1,3, Chian-Shiu Chien1,3, Chih-Chien Hsu4,5, Ying-Chun Jheng3,6, Mong-Lien Wang3,4,7, Shih-Hwa Chiou1,3,4,5, Yu-Bai Chou4,5, De-Kuang Hwang4,5, Tai-Chi Lin4,5, Shih-Jen Chen4,5, Yi-Ping Yang3,4,7.
Abstract
Angiotensin-converting enzyme 2 (ACE2) was identified as the main host cell receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its subsequent infection. In some coronavirus disease 2019 (COVID-19) patients, it has been reported that the nervous tissues and the eyes were also affected. However, evidence supporting that the retina is a target tissue for SARS-CoV-2 infection is still lacking. This present study aimed to investigate whether ACE2 expression plays a role in human retinal neurons during SARS-CoV-2 infection. Human induced pluripotent stem cell (hiPSC)-derived retinal organoids and monolayer cultures derived from dissociated retinal organoids were generated. To validate the potential entry of SARS-CoV-2 infection in the retina, we showed that hiPSC-derived retinal organoids and monolayer cultures endogenously express ACE2 and transmembrane serine protease 2 (TMPRSS2) on the mRNA level. Immunofluorescence staining confirmed the protein expression of ACE2 and TMPRSS2 in retinal organoids and monolayer cultures. Furthermore, using the SARS-CoV-2 pseudovirus spike protein with GFP expression system, we found that retinal organoids and monolayer cultures can potentially be infected by the SARS-CoV-2 pseudovirus. Collectively, our findings highlighted the potential of iPSC-derived retinal organoids as the models for ACE2 receptor-based SARS-CoV-2 infection.Entities:
Keywords: ACE2; COVID-19; SARS-CoV-2; SARS-CoV-2 pseudovirus; induced pluripotent stem cells; organoids; spike protein
Year: 2021 PMID: 33525682 PMCID: PMC7865454 DOI: 10.3390/ijms22031320
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923